Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

(2012) Ellen M. Mowry et al.   ANNALS OF NEUROLOGY

Multiple Sclerosis Lesions and Irreversible Brain Tissue Damage

(2012) Tim Sinnecker et al.   ARCHIVES OF NEUROLOGY

Severe Hypercalcemia Following Vitamin D Supplementation in a Patient With Multiple Sclerosis

(2012) Jacqueline F. Marcus   ARCHIVES OF NEUROLOGY

Current Status of Vitamin D Signaling and Its Therapeutic Applications

(2012) Carsten Carlberg et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Multiple sclerosis

(2012) Alyssa Nylander et al.   JOURNAL OF CLINICAL INVESTIGATION

A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis

(2012) Merja Soilu-Hänninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

(2012) Margitta T Kampman et al.   Multiple Sclerosis Journal

Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence

(2012) G Giovannoni et al.   Multiple Sclerosis Journal

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

(2012) Per Soelberg Sørensen et al.   Multiple Sclerosis Journal

Vitamin D and disease activity in multiple sclerosis before and during interferon-  treatment

(2012) K. I. Loken-Amsrud et al.   NEUROLOGY

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis

(2012) T. F. Runia et al.   NEUROLOGY

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis

(2012) T. Sinnecker et al.   NEUROLOGY

Fingolimod-associated macular edema: Incidence, detection, and management

(2012) N. Jain et al.   NEUROLOGY

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

(2012) Jan Dörr et al.   Trials

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation

(2012) Charles Pierrot-Deseilligny et al.   Therapeutic Advances in Neurological Disorders

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy

(2012) Nadja Borisow et al.   EPMA Journal

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine

(2012) Olga Golubnitschaja et al.   EPMA Journal

Rare variants in the CYP27B1 gene are associated with multiple sclerosis

(2011) Sreeram V. Ramagopalan et al.   ANNALS OF NEUROLOGY

Gestational vitamin D and the risk of multiple sclerosis in offspring

(2011) Fariba Mirzaei et al.   ANNALS OF NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection

(2011) John H. White   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Effects of vitamin D on the peripheral adaptive immune system: A review

(2011) Evelyn Peelen et al.   AUTOIMMUNITY REVIEWS

Genetic background of multiple sclerosis

(2011) A. Dessa Sadovnick   AUTOIMMUNITY REVIEWS

Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: Genomic and non-genomic mechanisms

(2011) Mark R. Haussler et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Vitamin D and cancer: a review of molecular mechanisms

(2011) James C. Fleet et al.   BIOCHEMICAL JOURNAL

Multiple sclerosis: current treatment algorithms

(2011) Jordi Río et al.   CURRENT OPINION IN NEUROLOGY

An estimate of the global reduction in mortality rates through doubling vitamin D levels

(2011) W B Grant   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Vitamin D3: a helpful immuno-modulator

(2011) Michelino Di Rosa et al.   IMMUNOLOGY

Treatment of multiple sclerosis: current concepts and future perspectives

(2011) Dorothea Buck et al.   JOURNAL OF NEUROLOGY

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

(2011) Joost Smolders et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study

(2011) Brenda Banwell et al.   LANCET NEUROLOGY

Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study

(2011) C Veauthier et al.   Multiple Sclerosis Journal

Sun Exposure, Vitamin D Intake and Progression to Disability among Veterans with Progressive Multiple Sclerosis

(2011) Tzu-Yun McDowell et al.   NEUROEPIDEMIOLOGY

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

(2011) M. S. Stein et al.   NEUROLOGY

Sun exposure and vitamin D are independent risk factors for CNS demyelination

(2011) R. M. Lucas et al.   NEUROLOGY

The Epidemiology of Multiple Sclerosis in Scotland: Inferences from Hospital Admissions

(2011) Adam E. Handel et al.   PLoS One

Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis

(2011) Jan Dörr et al.   PLoS One

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model

(2011) Stig Wergeland et al.   PLoS One

The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination

(2011) Volker Limmroth et al.   Therapeutic Advances in Neurological Disorders

Erratum

(2010)   ACTA NEUROLOGICA SCANDINAVICA

Vitamin D–Dependent Rickets, HLA-DRB1, and the Risk of Multiple Sclerosis

(2010) Sreeram V. Ramagopalan et al.   ARCHIVES OF NEUROLOGY

Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice

(2010) Jean-Claude Souberbielle et al.   AUTOIMMUNITY REVIEWS

Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients

(2010) Markus Bock et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Seasonality of admissions with multiple sclerosis in Scotland

(2010) Adam E. Handel et al.   EUROPEAN JOURNAL OF NEUROLOGY

Epigenetic Reduction in Invariant NKT Cells following In Utero Vitamin D Deficiency in Mice

(2010) S. Yu et al.   JOURNAL OF IMMUNOLOGY

Vitamin D and multiple sclerosis

(2010) Alberto Ascherio et al.   LANCET NEUROLOGY

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

(2010) Sreeram V Ramagopalan et al.   LANCET NEUROLOGY

Multiple sclerosis and solar exposure before the age of 15 years: case—control study in Cuba, Martinique and Sicily

(2010) F. Dalmay et al.   Multiple Sclerosis Journal

Correlation of self-assessed fatigue and alertness in multiple sclerosis

(2010) Nicholetta Weinges-Evers et al.   Multiple Sclerosis Journal

Environmental factors and their timing in adult-onset multiple sclerosis

(2010) Adam E. Handel et al.   Nature Reviews Neurology

Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis

(2010) Tzu-Yun McDowell et al.   NEUROEPIDEMIOLOGY

Primary neuroprotection: The Holy Grail of multiple sclerosis therapy

(2010) R. J. Fox   NEUROLOGY

Seasonal prevalence of MS disease activity

(2010) D. S. Meier et al.   NEUROLOGY

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

(2010) J. M. Burton et al.   NEUROLOGY

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production

(2010) B. R. Becklund et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis

(2009) Johannes Vogt et al.   ANNALS OF NEUROLOGY

Immunomodulatory effects of Vitamin D in multiple sclerosis

(2009) J. Correale et al.   BRAIN

1α,25-Dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in Human Monocytes

(2009) Cristiana Almerighi et al.   CYTOKINE

25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

(2009) Trygve Holmøy et al.   Multiple Sclerosis Journal

The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis

(2009) Douglas S. Goodin   PLoS One

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis

(2009) Joost Smolders et al.   PLoS One

Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases

(2009) D.A. Fernandes de Abreu et al.   PSYCHONEUROENDOCRINOLOGY

Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

(2009) Sreeram V. Ramagopalan et al.   PLoS Genetics

Vitamin D Status: Measurement, Interpretation, and Clinical Application

(2008) Michael F. Holick   ANNALS OF EPIDEMIOLOGY

Vitamin D–Dependent Rickets as a Possible Risk Factor for Multiple Sclerosis

(2008) Øivind Torkildsen et al.   ARCHIVES OF NEUROLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis

(2008) Helen Tremlett et al.   NEUROEPIDEMIOLOGY

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis

(2008) T. Hagenau et al.   OSTEOPOROSIS INTERNATIONAL